Gastric intestinal metaplasia: progress and remaining challenges
Journal of Gastroenterology · 2024
DOI: 10.1007/s00535-023-02073-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology, 2024. Verfasst von Qi-Yue Tong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, 155 N. Nanjing Street, Shenyang, 1100…. Hauptthemen laut MEDLINE: Gastritis, Atrophic, Stomach Neoplasms, Precancerous Conditions. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 163 Literaturangaben. Gefördert von: NCATS NIH HHS, National Natural Science Foundation of China, Ministère de l'Education Nationale, de la Formation professionnelle, de l'Enseignement Supérieur et de la Recherche Scientifique.
Abstract (Originalsprache)
Most gastric cancers arise in the setting of chronic inflammation which alters gland organization, such that acid-pumping parietal cells are lost, and remaining cells undergo metaplastic change in differentiation patterns. From a basic science perspective, recent progress has been made in understanding how atrophy and initial pyloric metaplasia occur. However, pathologists and cancer biologists have long been focused on the development of intestinal metaplasia patterns in this setting. Arguably, much less progress has been made in understanding the mechanisms that lead to the intestinalization seen in chronic atrophic gastritis and pyloric metaplasia. One plausible explanation for this disparity lies in the notable absence of reliable and reproducible small animal models within the field, which would facilitate the investigation of the mechanisms underlying the development of gastric intestinal metaplasia (GIM). This review offers an in-depth exploration of the current state of research in GIM, shedding light on its pivotal role in tumorigenesis. We delve into the histological subtypes of GIM and explore their respective associations with tumor formation. We present the current repertoire of biomarkers utilized to delineate the origins and progression of GIM and provide a comprehensive survey of the available, albeit limited, mouse lines employed for modeling GIM and engage in a discussion regarding potential cell lineages that serve as the origins of GIM. Finally, we expound upon the myriad signaling pathways recognized for their activity in GIM and posit on their potential overlap and interactions that contribute to the ultimate manifestation of the disease phenotype. Through our exhaustive review of the progression from gastric disease to GIM, we aim to establish the groundwork for future research endeavors dedicated to elucidating the etiology of GIM and developing strategies for its prevention and treatment, considering its potential precancerous nature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, 155 N. Nanjing Street, Shenyang, 110001, Liaoning, China.
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Affiliated Hospital of China Medical University, 155 N. Nanjing Street, Shenyang, 110001, Liaoning, China.
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, USA.
- Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, USA.
- Section of Gastroenterology and Hepatology, Department of Medicine, Departments of Pathology and Immunology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, USA.
- Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, 155 N. Nanjing Street, Shenyang, 110001, Liaoning, China. znwang@cmu.edu.cn.
Förderung
- NCATS NIH HHS
- National Natural Science Foundation of China
- Ministère de l'Education Nationale, de la Formation professionnelle, de l'Enseignement Supérieur et de la Recherche Scientifique
- National Center for Advancing Translational Sciences
- Department of Education of Liaoning Province
- Joint Fund for the Cross-Disciplinary in Medicine and Engineering of Science and Technology Program Projects of Liaoning Province
Zitieren
APA
Tong, Q. Y., Pang, M. J., Hu, X. H., Huang, X. Z., Sun, J. X., Wang, X. Y., Burclaff, J., Mills, J. C., Wang, Z. N., & Miao, Z. F. (2024). Gastric intestinal metaplasia: progress and remaining challenges. Journal of Gastroenterology. https://doi.org/10.1007/s00535-023-02073-9
Vancouver
Tong QY, Pang MJ, Hu XH, Huang XZ, Sun JX, Wang XY, et al. Gastric intestinal metaplasia: progress and remaining challenges. Journal of Gastroenterology. 2024. doi:10.1007/s00535-023-02073-9
BibTeX
@article{Tong2024,
author = {Tong, Qi-Yue and Pang, Min-Jiao and Hu, Xiao-Hai and Huang, Xuan-Zhang and Sun, Jing-Xu and Wang, Xin-Yu and Burclaff, Joseph and Mills, Jason C and Wang, Zhen-Ning and Miao, Zhi-Feng},
title = {Gastric intestinal metaplasia: progress and remaining challenges},
journal = {Journal of Gastroenterology},
year = {2024},
doi = {10.1007/s00535-023-02073-9}
}
EUVIMED